Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect
Author:
Publisher
Frontiers Media SA
Subject
Pharmacology (medical),Pharmacology
Reference21 articles.
1. A clinically significant interaction between warfarin and simvastatin is unique to carriers of the CYP2C9∗3 allele.;Andersson;Pharmacogenomics,2012
2. Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteers.;Ansermot;Drug Metab. Lett.,2008
3. Rivaroxaban: quantification by anti-FXa assay and influence on coagulation tests: a study in 9 Swiss laboratories.;Asmis;Thromb. Res.,2012
4. Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots.;Bosilkovska;Clin. Pharmacol. Ther.,2014
5. Letter by Bouatou et al regarding article, “polypharmacy and the efficacy and safety of Rivaroxaban versus warfarin in the prevention of stroke in patients with nonvalvular atrial fibrillation”.;Bouatou;Circulation,2016
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Common P-glycoprotein (ABCB1) polymorphisms do not seem to be associated with the risk of rivaroxaban-related bleeding events;Biochemia medica;2024-06-15
2. Features of drug-drug interactions rivaroxaban and calcium channel blockers depending on the ABCB1 genotype (rs1045642 and rs4148738) in patients 80 years of age and older with non-valvular atrial fibrillation;Acta Biomedica Scientifica;2024-01-14
3. Gene polymorphism as a cause of hemorrhagic complications in patients with non-valvular atrial fibrillation treated with oral vitamin K-independent anticoagulants;Therapeutic Advances in Cardiovascular Disease;2024-01
4. Genetic variants of ABCB1 and CES1 genes on dabigatran metabolism in the Kazakh population;CASP J INTERN MED;2024
5. Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk;Genes;2023-11-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3